UMC, Uppsala Monitoring Centre - Business Developer

Haeger & Carlsson; Stockholm; On-site; EUR 50 000 - 75 000; Full time

Job summary

Haeger & Carlsson is seeking a Business Developer for Uppsala Monitoring Centre to drive growth, expansion, and diversification. The ideal candidate will have experience in life sciences and tech, and a strong background in business development and analysis, with excellent analytical and financial skills.

Qualifications

• Experience in business development, analysis, or investments in life sciences or tech.
• Proven experience working in cross-functional teams.
• Understanding of business law for licensing is desirable.

Responsibilities

• Drive growth and diversification for UMC.
• Focus on in-licensing and business development opportunities.
• Interface with multiple stakeholders.

Skills

Business development

Analytical skills

Financial acumen

Interpersonal skills

Job description

Business Developer at UMC – Drive Growth and Diversification.

Hæger & Carlsson is recruiting a Business Developer for Uppsala Monitoring Centre (UMC). A new position within the UMC organisation reporting to the Head of the External Engagement department. The Business developer will drive growth, expansion and diversification and primarily focus on in-licensing and business development opportunities in line with the missions of the organization.

Qualification Requirements:

• Experience working with either business development, analysis and/or investments within life sciences, data sciences or tech.

• Proven experience working in complex cross-functional teams and to interface with multiple stakeholders internally and externally

• Business development including business intelligence, due diligence and negotiations

• Excellent analytical skills and a profound financial acumen

• Working understanding of business law for licensing and mergers & acquisitions is desirable

• Understanding of product development of digital solutions and services is desirable

About UMC

Uppsala Monitoring Centre (UMC) is an independent, self-funded, non-profit foundation established in 1978 dedicated to safer use of medicines and vaccines. Through an agreement between the Government of Sweden and the World Health Organization (WHO), UMC operates the Programme for International Drug Monitoring, supporting over 180 member countries and regions in strengthening safety surveillance, and maintains VigiBase, the WHO global database of adverse event reports. In addition, UMC provides international standards and related digital solutions for secure exchange of pharmacovigilance data, including a global medicine and vaccine terminology for identification of medicinal products. With around 200 staff, UMC advances the science of pharmacovigilance and transforms its practice through technological innovation.
Please read more at who-umc.org/

Please apply through haegercarlsson.com
Questions are answered by:

Alexander Johansson, +46 (0)73 – 77 77 233, [e-mail]
Anna Wikman, [phone], [e-mail]